1. Home
  2. Products
  3. Cardiovascular & Renal
  4. IDK® Zonulin ELISA Stool (Health Canada)

IDK® Zonulin ELISA Stool (Health Canada)

Item #: K 5600 Categories: ,


Available with Lead Time!

Method: ELISA
Sample Type (Matrix): Stool
Sample Volume: 15 mg
Species: Human
Incubation time: 2h 10m
Standard Range: 0.25 - 64 ng/ml
Size: 96 wells
Regulatory Status: Health Canada Licensed. Not for sale in the U.S.
Kit Manual: Download
Data Sheet: Download

The IDK® Zonulin ELISA (Stool) is intended for the quantitative determination of zonulin family peptides (ZFP) in stool to assess intestinal permeability.

Health Canada Licensed. For Laboratory Professional Use Only.

Zonulin is a tight-junction regulating protein in the digestive tract. Zonulin binds to a specific receptor on the surface of intestinal epithelia and triggers a cascade of biochemical events, which induces tight junction disassembly and a subsequent permeability increase of the intestinal epithelia, allowing some substances to pass through and activate immune reactions.

An increased intestinal permeability, also known as 'leaky gut,' is associated with metabolic syndrome, obesity, and several autoimmune, inflammatory, and neoplastic diseases. Based on the evidence, leaky gut plays a meaningful role in conditions such as multiple sclerosis, rheumatoid arthritis, asthma, and inflammatory bowel diseases.

If your lab is testing at high volumes, the IDK® Zonulin ELISA (Stool) is also available in a customized bulk pack (20 plates).

Developed by Immundiagnostik AG.

Test Principle of the IDK® Zonulin ELISA (Stool)

The IDK® Zonulin ELISA (Stool) is based on the method of competitive ELISA.

As a first preparation step, biotinylated ZFP is added to the samples, standards, and controls. Afterward, aliquots of the treated samples, standards, and controls are transferred and incubated in microtiter plate wells coated with polyclonal anti-ZFP antibodies. During the incubation, the free target antigen in the samples competes with the biotinylated ZFP for the binding of the polyclonal anti-ZFP antibodies immobilized on the microtiter plate wells. The unbound components are removed by a washing step.

During a second incubation step, peroxidase-labeled streptavidin, which binds to the biotinylated ZFP, is added to each microtiter well. After a washing step to remove the unbound components, the peroxidase substrate tetramethylbenzidine is added.

Finally, the enzymatic reaction is terminated by an acidic stop solution. The color changes from blue to yellow, and the absorbance is measured in the photometer at 450 nm. The intensity of the yellow color is inversely proportional to the ZFP concentration in the sample; this means a high ZFP concentration in the sample reduces the concentration of the biotinylated ZFP bound to the immobilized anti-ZFP antibodies and lowers the photometric signal.

A dose-response curve of absorbance unit (optical density, OD at 450 nm) vs. concentration is generated using the values obtained from the standard.

Additional information

Weight35.5 oz
Dimensions6.5 × 10 × 4.5 in
Social media & sharing icons powered by UltimatelySocial

Become an IDK Insider!

Join our mailing list to receive the latest news and updates from Immundiagnostik, Inc.


You have Successfully Subscribed!